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ABSTRACT
G protein-coupled receptors (GPCRs) are involved in all
humanphysiological systemswhere theyare responsible
for transducing extracellular signals into cells. GPCRs
signal in response to a diverse array of stimuli including
light, hormones, and lipids, where these signals affect
downstream cascades to impact both health and disease
states. Yet, despite their importance as therapeutic tar-
gets, detailed molecular structures of only 30 GPCRs
have been determined to date. A key challenge to their
structure determination is adequate protein expression.
Here we report the quantiﬁcation of protein expression in
an insect cell expressionsystemfor all 826humanGPCRs
using two different fusion constructs. Expression char-
acteristics are analyzed in aggregate and among each of
the ﬁve distinct subfamilies. These data can be used to
identify trends related to GPCR expression between dif-
ferent fusion constructs and between different GPCR
families, and to prioritize lead candidates for future
structure determination feasibility.
KEYWORDS G protein-coupled receptors, insect,
protein expression, surface expression analysis, fusion
construct
INTRODUCTION
Gprotein-coupled receptors (GPCRs) are of great importance
for physiological function and constitute the largest family of
human membrane proteins, with 826 members (Fig. 1A and
Table 1). Also termed seven transmembrane (7TM) receptors
because of their conserved core architecture of seven trans-
membrane alpha-helices, GPCRs can recognize and bind
many diverse signaling molecules including odorants, neu-
rotransmitters and hormones (Stevens et al., 2013). Drugs
targeting GPCRs comprise as much as 40% of all marketed
drugs, and the receptors are implicated in many medical
conditions such as heart disease, neurological disorders,
cancer and obesity (Rask-Andersen et al., 2014).
Detailed three-dimensional structural information is of great
importance for understanding the physiological functions of
GPCRs and for designing new drugs to target them. In recent
years, persistent efforts of researchers and implementation of
new technologies have contributed to the accelerated devel-
opment of GPCR structural studies. In 2000, the ﬁrst mam-
malian GPCR structure was elucidated (Palczewski et al.,
2000). Since then, the structures of 30 different GPCRs
(Fig. 1A, 1B and Table 1) have been reported. While this rep-
resents real progress, it comprises only a fraction of almost 300
GPCRs that are known to be involved in psychiatric diseases,
cancer, and other maladies, and an even smaller fraction of the
826 GPCRs found in humans (Katritch et al., 2013).
Given the challenges in structurally determining GPCRs
and the large number of structures that remain to be solved,
one approach to maintain the recently developed momentum
is to prioritize those GPCRs with the highest likelihood of
success. As protein expression is the critical ﬁrst step in the
structure determination process, it makes sense to pursue the
receptors with high expression levels ﬁrst as these are most
likely to provide thehighest yield after puriﬁcation. In this study,
we applied a comprehensive family-wide approach to express
all 826 human GPCRs using two different construct designs.
The comprehensive results (Table S1) are provided to
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facilitate future biochemical, pharmacological, and structural
studies.
APPROACH
In order to evaluate the relative expression levels of all 826
human GPCRs, we developed a simple strategy that could
be applied uniformly to each receptor involving construct
design, expression, and quantiﬁcation. GPCRs can vary
greatly in length, some having more than 1000 residues, but
most consist of 200–400 residues (Fig. 1C), primarily con-
stituting the 7TM helices. While the full length protein is
undoubtedly important for native in vivo function, in these
studies we have focused on the receptors’ 7TM domain.
Thus, the ﬁrst step in construct design was to truncate the
ﬂexible N- and C-termini based on the computationally pre-
dicted 7TM regions (See “MATERIALS AND METHODS”).
The second step in construct design was to add a fusion
partner. Fusion partners have often been useful for
increasing expression and stabilizing membrane proteins
(Chun et al., 2012). Here we used Cytochrome b562 RIL
(BRIL), a soluble alpha-helical protein that has been crys-
tallized and structurally characterized by itself to a resolution
of 1.8 Å (PDB ID 1M6T, MW 11.9 kDa) and with the A2A
adenosine receptor to a resolution of 1.8 Å (PDB ID 4EIY).
Two constructs were designed and generated for each
GPCR, one with BRIL attached at the N-terminus truncation
site (Nt_BRIL) and one with BRIL inserted in intracellular
loop 3 (ICL3_BRIL; Fig. 2A) as described in MATERIALS
AND METHODS. Both design approaches have led to
crystallographic characterization of several GPCRs, includ-
ing 1.8 Å resolution structures of the A2A adenosine and
delta-opioid receptors (Liu et al., 2012; Fenalti et al., 2014).
Constructs were then cloned into a modiﬁed pFastBac1
vector for expression in Spodoptera frugiperda (Sf9) cells
(See “MATERIALS AND METHODS”). Sf9 cells were selec-
ted based on their demonstrated success in other GPCR
structural studies. Four types of expression systems have
been employed in protein production for structural studies of
GPCRs to date: E. coli, yeast, mammalian cells and insect
cells (Zhao and Wu, 2012). We chose the Spodoptera frugi-
perda (Sf9) expression system as it presently has the most
established track record, given that 25 of the 30 structurally
determined GPCRs were expressed in this system (Fig. 1B).
In this study, expression levels were detected using a ﬂu-
orescent probe that consists of an α-ﬂag FITC-coupled anti-
body that speciﬁcally recognizes a FLAG sequence inserted
at the N-terminus of each construct (Fig. 2). Receptor cell
surface expression and total receptor expression was deter-
mined by ﬂow cytometry using a ﬂuorescence signal detected
from cells pre-incubated with the ﬂuorescent probe in the
absence (For surface expression % and surface density val-
ues) or presence of a mild detergent (For total expression %
and total density values), respectively. This approach allowed
us to quantify the percentage of cells expressing GPCRs, as
well as the relative receptor expression, at the surface or
overall (total).
RESULTS
General GPCR expression levels
In this project a total of 1652 constructs, 826 Nt_BRIL con-
structs, and 826 ICL3_BRIL constructs, were cloned and
expressed as summarized individually in Table S1 and col-
lectively in Table 2. Of all these, about 7% (119 of 1,652)
show a high level of expression (surface expression >80%;
Table 3).
Comparison of expression between Nt_BRIL
and ICL3_BRIL constructs
The BRIL soluble domain was inserted into the GPCR to
promote expression by stabilizing the receptor and increas-
ing solubility (Fig. 2A). As expected, expression levels varied
between the two different constructs of each receptor. In this
study, the Nt_BRIL construct was generally more effective
than ICL3_BRIL construct at promoting both total expression
and surface expression (Fig. 3 and Table 4). Twenty-eight of
the Nt_BRIL constructs displayed surface expression >90%
Figure 1. Overview of human GPCRs. (A) A Family tree of
the 826 human GPCRs. (B) Including Rhodopsin in 2000,
structures have been determined for 30 distinct GPCRs to date.
Of these, the vast majority were expressed in Sf9 cells and
GPCRs expressed in other kinds of cell lines are marked in
gray. (C) The majority of GPCRs consist of 200–400 amino
acids, with GPR98 from the Adhesion family the single largest
at 6,306 amino acids.
Table 1. The families of 826 GPCRs and their structures
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versus 22 of the ICL3_BRIL constructs; 325 of the Nt_BRIL
constructs had a surface density above 100 MFU (mean
ﬂuorescence units) versus 53 of the ICL3_BRIL constructs.
The majority of Nt_BRIL constructs (424) had surface
expression levels between 30%–60%, while most of
ICL3_BRIL constructs (390) had surface expression levels
between 10%–40%. For the Nt_BRIL constructs, the number
of GPCRs with total percent expression >90% is larger (358)
than for ICL3_BRIL constructs (306).
High expression for the Nt_BRIL construct of a receptor
did not always correspond to high expression for the
ICL3_BRIL construct. For example, 54 Nt_BRIL and 65
α-FLAG α-FLAG + Triton
Surface expression test Total expression test
























































































































Figure 2. Experimental design. (A) Constructs were designed by truncating the ﬂexible N- and C-termini and inserting BRIL at
either the N-terminus (Nt_BRIL) or intracellular loop 3 (ICL3_BRIL). (B) Constructs were then inserted into the pFastBac 1 vector for
Sf9 expression. (C) FITC ﬂuorescence was used to measure the percentage of cells expressing the GPCR, as well as density of
GPCRs for those cells. Surface and total expression were measured by adding α-ﬂag FITC with and without Triton, respectively.
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ICL3_BRIL constructs had surface expression levels >80%,
yet only 22 receptors expressed at this level for both con-
structs (Tables S2–S4). Similarly, 164 Nt_BRIL and 309
ICL3_BRIL constructs had surface expression <30%, com-
pared to 94 receptors with low expression for both constructs.
In an attempt to determine a pattern in receptor prefer-
ence for Nt_BRIL versus ICL3_BRIL, we grouped and ana-
lyzed expression data according to receptor family (Fig. 4).
Few differences were found between GPCR families in
terms of the percentage of cells that expressed either con-
struct (Fig. 4A and 4C). Total receptor expression density
varied more from family to family, with Glutamate and
Adhesion family receptors exhibiting the highest expression
density for Nt_BRIL constructs (Fig. 4B). In general, Nt_BRIL
constructs had higher expression density than ICL3_BRIL
constructs for Rhodopsin, Frizzled/Taste2, and Adhesion
family receptors, while ICL3_BRIL constructs performed
better for Glutamate family receptors.
The average percentage of cells expressing receptors on
their surface was fairly constant across the families for
Nt_BRIL constructs (Fig. 5A). ICL3_BRIL constructs, on the
other hand, exhibited much higher surface expression per-
centages for Secretin family receptors than for other families
(Fig. 5C). Similarly, Secretin family receptors exhibited the
highest surface density for ICL3_BRIL constructs (Fig. 5D).
Expression between the GPCR families
The expression levels are summarized in Table 5 from the
data analysis of the different GPCR families. The surface
density represents the mean ﬂuorescence intensity of all
cells expressing the target receptors, and the surface per-
centage represents the ratio of cells expressing the target
receptor from the total number of cells. Here we compared
the surface expression percentage, surface density, total
expression percentage and total density of different families.
For the Nt_BRIL constructs, the surface expression level
order between families is: Frizzled/Taste2 = Secretin = Adhe-
sion > Glutamate > Rhodopsin. With the BRIL fusion at the
N-termini, the Secretin family showed the best expression
Table 2. Statistics of expression levels among the 1,652 GPCR constructs1
Construct(s) % Surface expression2 Surface density3 % Total expression4 Total density5
Range 1.85–97.00 11.77–865.22 0.50–98.75 13.80– 812.69
Mean 44.71 74.14 75.84 258.09
Median 42.98 57.04 85.18 145.50
25th percentile 26.74 32.80 61.14 60.50
75th percentile 60.56 95.45 93.60 403.52
1 Most of indexes obey a skewed distribution except for surface percentage. The median and the quartiles of 1,652 constructs were obtained
by the SPSS.
2 Surface expression: The ratio of all the cells expressing the target receptors on the membrane to total cells.
3 Surface density: The ratio of all the ﬂuorescence of membrane proteins to total cells.
4 Total expression: The ratio of cells expressing the target receptors to total cells.
5 Total density: The ratio of all the ﬂuorescence to total cells.
Table 3. High expressing GPCR constructs by family1
Family Nt_BRIL ICL3_BRIL Total2 Non-duplicates3 No current structure4
Rhodopsin 26 45 71 61 53
Secretin 2 5 7 6 6
Glutamate 9 3 12 9 9
Frizzled/Taste 2 7 3 10 8 7
Adhesion 10 8 18 12 12
Total 54 64 118 96 87
1 High expression deﬁned as >80% surface expression, which is the ratio of all the cells expressing the target receptors on the membrane to
total cells.
2 Sum of high expressing Nt_BRIL and ICL3_BRIL constructs.
3 Total of unique GPCRs with high expression (counting the GPCRs that showed high surface expression in both Nt_BRIL and ICL3_BRIL
constructs only once).
4 The number of unique GPCRs with high expression for which no three-dimensional structure is currently available.
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levels in these Sf9 cultures. For the ICL3_BRIL constructs,
the Secretin family constructs had the highest surface per-
centage and surface density. On the contrary, the ICL3_BRIL
constructs of the Rhodopsin family showed the lowest sur-
face percentage and lowest expression level.
In Nt_BRIL constructs, Glutamate and Adhesion families
showed the highest surface density. For the total density of
ICL3_BRIL constructs, there are notable differences
between the different families with expression ranking as:
Glutamate > Secretin > Adhesion > Frizzled/Taste2 > Rho-
dopsin family (Fig. 4). When the fusion partner BRIL is
inserted at ICL3, Glutamate family receptors collectively
produced the best expression levels, although Rhodopsin
family receptors constitute the majority of the receptors
whose surface expression levels exceed 80% (Fig. 4).
For some receptors, the Nt_BRIL construct showed a
high expression level, while the ICL3_BRIL construct
showed low expression (Table 6). This pattern is observed in
Rhodopsin, Secretin, Glutamate, and Frizzled/Taste2
receptor families, but potentially for different reasons (dis-
cussed below). For example, for the receptors CML1,
CELR3, and FZD9—Frizzled/Taste2 family receptors—both
the total density and surface density values of the Nt_BRIL
constructs are higher than the ICL3_BRIL constructs, indi-
cating the Nt_BRIL construct is not only expressed, but also
secreted better than the ICL3_BRIL construct. For the GRM2
receptor—a Glutamate family member—although the sur-
face density of its Nt_BRIL construct is higher than its
ICL3_BRIL construct, for the total density, the result is just
the opposite. This means that for the GRM2 receptor, the
ICL3_BRIL construct was expressed much better than the
Nt_BRIL construct inside the cell, so the receptor had some
issue in terms of trafﬁcking to the cell membrane in the
ICL3_BRIL construct (Table 6).
Another interesting ﬁnding is that individual receptors in
some subfamilies with high sequence conservation dis-
played expression levels with high variability between sub-
family members and constructs. For example, the β-
adrenergic receptors subfamily within the rhodopsin family is
composed of three members. The sequence identity of the
7TM helices and loop regions between the β2- and β3-
adrenergic receptors is very high (65%), but the receptors
displayed different expression levels with Nt_BRIL and
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Figure 3. Distribution of total and surface expression among constructs. Comparison of total expression percentage (A), total
expression density (B), surface expression percentage (C), and surface expression density (D) between Nt_BRIL and ICL3_BRIL
constructs collectively.
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true for adenosine subfamily receptors AA2AR and AA2BR,
the sequence identity between these members is 61%, but
the expression level of AA2BR is much lower than the
AA2AR, regardless of construct in this study (Table 7). In the
metabotropic glutamate and lysophosphatidic acid receptor
subfamilies, mGluR7 and LPAR1 also show very low
expression levels.
Finally, the Rhodopsin family can be further subdivided
into olfactory and non-olfactory receptors with 422 and 297
members, respectively. The olfactory receptors did not
express well with either fusion protein (Table 8), but gener-
ally did better with Nt_BRIL constructs (median surface
percent = 38.6%) than with ICL3_BRIL constructs (median
surface percent = 23.6%). Only 2 Nt_BRIL olfactory con-
structs had a surface percent above 80%, with 72 Nt_BRIL
olfactory constructs above 60%; none of the ICL3_BRIL
constructs had a surface percent above 80% and only 2 had
a surface percent above 60%.
DISCUSSION
Identifying trends in the results
The GPCR structures that have been solved with fusion
partners did not share the same precise placement loca-
tion for their fusion partner, as in they did in this study,
therefore, a lack of positional optimization can be expected
when reviewing these results. Yet, we can deﬁne some
general trends from the large amount of data collected in
this study. Overall, the expression levels of the 826
Nt_BRIL GPCR constructs was higher than at the ICL3_
BRIL constructs, it can be concluded that a well-organized
N-terminus is helpful for effective trafﬁcking of the post-
translational receptor to cell membrane. Another possible
conclusion is that the N-terminal fusion partner may make
the tertiary structure more stable and less toxic to the cell
as a result.
For the adrenergic receptors in the Rhodopsin family, β1
and β2 adrenergic receptors have high sequence identity.
However, they displayed very different expression levels in
this Sf9 expression system. This is evident that the expres-
sion level or the property of receptors can be affected by very
few residues. Just as in the construct optimization process,
point mutation screening could identify a more stabilizing
version of the protein (Zhang et al., 2014). From the
expression data of the Frizzled/Taste2 family, it can be
concluded that the expression level is closely related to the
protein’s properties. In other words, a good expression level
is one of the characteristics of a stable receptor.
The differences between non-olfactory and olfactory
receptors within the Rhodopsin family are mainly reﬂected in
longer extracellular loops and the conserved properties of
the 7TM domain. After analysis of the receptor’s sequence
data from Uniprot, generally, the length of extracellular loop 2
(ECL2) and ECL3 in most olfactory receptors was found to
be more than 20 and 35 amino acids, respectively. However,
for the non-olfactory receptors, either ECL1 or ECL2 is
longer than 20 amino acids, or both loops are shorter than 20
amino acids. This observation is distinct from the trend of
GPCRs in general, of which the 7TM helical bundle has been
the most conserved component (Katritch et al., 2012),
across the over 400 various odorant receptors (Jiang and
Matsunami, 2015), the most conserved domains are the
intracellular loops and the seventh transmembrane helix
Table 4. Statistics of GPCR expression levels by construct
Construct(s) % Surface expression1 Surface density2 % Total expression3 Total density4
Nt_BRIL construct
Range 1.85–97.00 18.51–481.97 1.25–98.75 18.82–1812.69
Mean 48.12 100.83 75.94 306.91
Median 46.63 85.64 86.95 210.55
25th percentile 32.95 62.73 58.26 86.12
75th percentile 62.85 124.80 94.45 480.28
ICL3_BRIL construct
Range 3.45–96.65 11.77–865.22 0.50–98.50 13.80–1478.02
Mean 41.29 47.44 75.74 209.27
Median 38.35 33.91 84.05 88.51
25th percentile 21.59 24.13 63.51 37.85
75th percentile 56.58 50.45 92.74 306.69
1 Surface expression: The ratio of all the cells expressing the target receptors on the membrane to total cells.
2 Surface density: The ratio of all the ﬂuorescence of membrane proteins to total cells.
3 Total expression: The ratio of cells expressing the target receptors to total cells.
4 Total density: The ratio of all the ﬂuorescence to total cells.
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(helix VII), while the sequence diversity of helices III, IV, and
V to which the odorant molecules bind is very high (Gao
et al., 2010; de March et al., 2015). These two characteristics
may contribute to the low expression level and instability of
the olfactory receptors. From the perspective of function, one
odorant can stimulate several kinds of odorant receptors,
meanwhile one single odorant receptors can be activated by
numerous different odorants (Sanz et al., 2014). Therefore
the functional peculiarity of olfactory receptors may reﬂect
their particularity in structure.
Glycosylation is also known to affect the ability of the
receptor to reach the cell surface. This fact is especially
relevant to some of the Glutamate family receptors, like
GABAB1 and GPRC6. GABAB1 contains ﬁve N-glycosylation
sites in the extracellular domain; when mutating all ﬁve sites,
low surface expression was seen 24 h post-transfection
(Deriu, 2005; Norskov-Lauritsen and Brauner-Osborne,
2015). GPRC6 was shown to be N-glycosylated at seven
different sites in vitro in the extracellular domain. Mutation of
any two sites was shown to affect the receptor’s surface
expression (Norskov-Lauritsen and Brauner-Osborne, 2015;
Norskov-Lauritsen et al., 2015). However, not all the Gluta-
mate family receptors require glycosylation to maintain sur-
face expression. For example, the inhibition N-glycosylation
of mGlu1R did not change its surface expression level
(Mody, 1999; Norskov-Lauritsen and Brauner-Osborne,
2015). In this study, truncation of the extracellular domain
which contains most of the glycosylation sites contributed to
the low expression levels of both GABAB1 and GPRC6A
receptors.
Finally, the expression level on the membrane maybe
also affected by the exogenous environment. If one receptor
is co-expressed or interacts with another receptor in its
native physiological environment, the receptor maybe
unstable and expressed poorly in the heterologous experi-
mental system.
The expression study of these 1,652 GPCR constructs
identiﬁed some familial trends, and importantly, identiﬁed
several high expressing GPCRs for which no structural data
currently exists. Based on these ﬁndings, future studies can
prioritize work on these high expressing receptors and work
to further optimize the construct and identify stabilizing
Total expression of Nt_BRIL
Total expression of ICL3_BRIL
Total density of Nt_BRIL
Total density of ICL3_BRIL
GPCR family
GPCR family GPCR family
GPCR family
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2

























































Figure 4. Total expression characteristics by GPCR family and construct. Distributions among GPCR families are shown for
total percentage of cells expressing GPCRs (A and C) and total density of GPCRs (B and D) for Nt_BRIL (A and B) and ICL3_BRIL (C
and D) constructs. Graphs are plotted as median values for the Rhodopsin, Secretin, Glutamate, Frizzled/Taste2, and Adhesion
families with 719, 16, 22, 36, and 33 members, respectively. Error bars indicate ﬁrst quartile from the median.
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Design of truncations and BRIL fusion sites was based on
similarity with previously solved structures of GPCRs from
different families. Unique receptor sequences for 826
GPCRs were derived from Uniprot, and 3D structural
models were generated for each receptor’s 7TM domain
with the automated ICM Build Model tool (Abagyan et al.
2015) using alignment with the closest homology template
(Katritch, 2013). Structure-based positional Ballesteros-
Weinstein (BW) numbers were assigned from the structural
alignments with the templates as described in GPCRDB
(Isberg et al., 2015).
The N-terminal truncation sites were designed using
predicted structural features in the receptor’s N-termini
derived from the corresponding structural templates. For
those cases where the N-terminus included important
structural elements that were resolved in the 3D template,
the truncation site was designed upstream of this structural
element. Thus, for Secretin family GPCRs, the N-termini
were truncated at the ﬁrst residues attributed to their 7TM
domains (Siu et al., 2013). For chemokine and other Rho-
dopsin family receptors, which have the N-terminal Cysteine
residues predicted to make an important disulﬁde bond to a
Cysteine in ECL3, this prospective disulﬁde bond was
included in the construct (Wu et al., 2010; Hanson et al.,
2012). Otherwise, for Rhodopsin family receptors that had a
missing or truncated N-terminus in their closest structural
template, we used a default truncation upstream of the
beginning of helix I at BW position 1.19.
The C-terminal truncation was universally applied at BW
position 7.78, which in most receptors corresponds to the
site ∼10 residues after the end of helix VIII. The constructs
thus include potential Cysteine palmitoylation sites in helix
VIII residues, when present.
The N-terminal BRIL fusion (Nt_BRIL) constructs placed
the BRIL sequence at the truncated position of the receptor
N-terminus as described above.
Surface expression of Nt_BRIL
Surface expression of ICL3_BRIL
Surface density of Nt_BRIL
Surface density of ICL3_BRIL
GPCR family
GPCR family GPCR family
GPCR family
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2
Rhodospsin Secretin Glutamate AdhesionFrizzled/
TAS2
































































Figure 5. Surface expression by GPCR family. Distributions among GPCR families are shown for percentage of cells expressing
GPCRs on their surface (A and C) and density of GPCRs on the surface (B and D) for Nt_BRIL (A and B) and ICL3_BRIL (C and D)
constructs. Error bars indicate ﬁrst quartile from the median. Graphs are plotted as median values for the Rhodopsin, Secretin,
Glutamate, Frizzled/Taste2, and Adhesion families with 719, 16, 22, 36, and 33 members, respectively. Error bars indicate ﬁrst
quartile from the median.
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The ICL3 BRIL insertion (ICL3_BRIL) constructs were
designed based on truncated sequences using insertion
sites in ICL3 as in the construct that was used to solve the
crystal structure of 5HT2B (Wacker et al., 2013). According to
this design, the BRIL sequence was inserted between BW
positions 5.69 and 6.25, replacing ICL3 residues between
Table 5. Median expression levels by family and construct1
Construct(s) % Surface expression2 Surface density3 % Total expression4 Total density5
Rhodopsin
Nt_BRIL 44.35 84.62 85.45 179.45
ICL3_BRIL 37.15 33.01 83.10 73.38
Secretin
Nt_BRIL 62.28 86.23 85.30 200.18
ICL3_BRIL 75.43 63.79 93.13 371.82
Glutamate
Nt_BRIL 53.03 124.81 84.00 413.80
ICL3_BRIL 42.83 53.27 91.70 700.13
Frizzled/Taste 2
Nt_BRIL 62.18 76.18 91.28 327.45
ICL3_BRIL 41.13 35.99 77.63 151.70
Adhesion
Nt_BRIL 62.15 99.97 91.90 476.01
ICL3_BRIL 44.65 42.38 86.30 250.56
1 Values are given as medians from the Rhodopsin, Secretin, Glutamate, Frizzled/Taste2, and Adhesion families with 719, 16, 22, 36, and 33
members, respectively.
2 Surface expression: The ratio of all the cells expressing the target receptors on the membrane to total cells.
3 Surface density: The ratio of all the ﬂuorescence of membrane proteins to total cells.
4 Total expression: The ratio of cells expressing the target receptors to total cells.
5 Total density: The ratio of all the ﬂuorescence to total cells.
Table 6. Representative receptors within GPCR families with high expressing Nt_BRIL constructs and low expressing ICL3_BRIL
constructs
Construct(s) % Surface expression1 Surface density2 % Total expression3 Total density4
CML1 (Rhodopsin)
Nt_BRIL 82.80 50.80 93.25 88.44
ICL3_BRIL 37.35 32.94 45.35 35.94
CELR3 (Secretin)
Nt_BRIL 94.40 163.13 92.55 812.34
ICL3_BRIL 3.50 137.70 0.50 108.65
GRM2 (Glutamate)
Nt_BRIL 92.30 100.26 85.40 313.66
ICL3_BRIL 43.70 38.69 91.60 1404.69
FZD9 (Frizzled/Taste2)
Nt_BRIL 94.15 197.92 91.20 592.72
ICL3_BRIL 31.35 99.11 71.50 437.76
1 Surface expression: The ratio of all the cells expressing the target receptors on the membrane to total cells.
2 Surface density: The ratio of all the ﬂuorescence of membrane proteins to total cells.
3 Total expression: The ratio of cells expressing the target receptors to total cells.
4 Total density: The ratio of all the ﬂuorescence to total cells.
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these positions. In some rare cases when helices V and VI
were shorter than in the template, additional residues from
ICL3 were added to keep the helical structure in helices V
and VI the same as in the 5HT2B construct.
Plasmid constructs
Gene synthesis and codon optimization was performed by
GeneScript. The method of overlap extension PCR cloning
was used to subclone the protein gene into the vector which
is a simple and reliable way to create recombinant plasmids.
The expression vector, designated as pFastBac 1, was a
modiﬁed vector (Invitrogen) containing an expression cas-
sette with a BamHI ﬂanked HA signal sequence followed by
a FLAG tag at the N-terminal and with a 10× His tag at the
C-terminal. Once the recombinant donor plasmids were
obtained, the cloning core transfected them to the competent
DH10Bac E. coli cells which contain bacmid and helper to
facilitate the combination of the donor and bacmid into a
recombinant bacmid.






Total density Sequence identity




ADRB1 79.35 90.30 55.61 70.93 97.95 94.90 456.69 299.99 54 56
ADRB2 42.50 71.10 199.68 47.83 97.45 95.35 480.55 380.84 – 65











Adenosine NB1 ICB2 NB ICB NB ICB NB ICB AA2BR (%)
AA2AR 96.2 91.45 184.82 142.46 81.2 77.9 211.41 286.44 61
AA2BR 31.7 23.80 115.3 30.81 41.15 79.15 483.4 110.84 –
1 Nt_BRIL.
2 ICL3_BRIL.
Table 8. The expression level of N_BRIL and ICL3-BRIL constructs of olfactory receptors and non-olfactory receptors from the
Rhodopsin family
Construct(s) % Surface expression1 Surface density2 % Total expression3 Total density4
Olfactory Rhodopsin (n = 422)
Nt_BRIL 38.60 100.61 85.45 197.77
25th percentile 26.73 71.84 50.08 86.09
75th percentile 54.95 140.72 94.43 518.18
ICL3_BRIL 23.60 25.93 73.95 41.31
25th percentile 15.95 20.21 54.32 27.71
75th percentile 38.00 34.11 88.33 72.02
Non-Olfactory Rhodopsin (n = 297)
Nt_BRIL 52.10 70.07 85.55 164.01
25th percentile 40.65 49.48 67.50 78.03
75th percentile 66.95 95.46 95.30 400.54
ICL3_BRIL 58.15 47.53 91.50 303.00
25th percentile 44.25 36.32 80.10 176.40
75th percentile 74.95 66.41 94.80 458.35
1 Surface expression: The ratio of all the cells expressing the target receptors on the membrane to total cells.
2 Surface density: The ratio of all the ﬂuorescence of membrane proteins to total cells.
3 Total expression: The ratio of cells expressing the target receptors to total cells.
4 Total density: The ratio of all the ﬂuorescence to total cells.
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Cell culture and transfection
BV (baculovirus) expression is a high throughput platform
supporting biomass production for GPCR structure and
function studies. The platform transfects the insects cells
(Sf9) with the recombinant bacmids provided by the cloning
core to produce recombinant baculovirus. Recombinant
baculoviruses have been widely used as vectors to express
heterologous genes in cultured insect cells. High-titer
recombinant baculovirus (>108 viral particles per mL) was
obtained using the Bac-to-Bac Baculovirus Expression
System (Invitrogen). Forty mL cells were harvested by cen-
trifugation and stored at −80°C until use.
Quantitation of protein expression
The monoclonal ANTI-FLAG®M2-FITC (Sigma-Aldrich:
F4049), which is a monoclonal antibody covalently conjugated
to ﬂuorescein isothiocyanate (FITC), can recognize the FLAG
sequence at the N-terminus (Hanson et al., 2007). Therefore,
α-ﬂag FITC (2.5 µg/mL) was added to cells to quantify the
percentage of cells with surface-expressing GPCRs and the
density (mean ﬂuorescence intensity; MFI) of GPCRs on the
surface of those cells. α-Flag FITC (2.5 µg/mL)with 1.5%Triton
was added to cells to quantify the total expression levels which
includes total percentageand total density. For total andsurface
FITC expression assay, we used 10 µL FITC with and without
Triton working solution plus 10 µL of cells, incubate at 4°C for
20 min, add 180 µL 1× TBS (straight TBS, without BSA), then
ran the assay on a Guava ﬂow cytometer. The Guava Express
Plus GRN histogram statistics provide the count, cells/mL,
mean signal intensity, and %CV for each population within a
marker. Additionally, the% of total shows the percentage of the
datadisplayed in that plot. Here,weuse the data ofmean signal
intensity and % of total and surface expression.
Statistical analysis
The data was analyzed by the software of Statistical Product
and Service Solution (SPSS) which can be used to do cor-
relation analysis and cluster analysis. Through the K-S test
by SPSS, most of the indexes indicated the expression levels
in this study conform to a skewed distribution. The expression
data distribution was analyzed by GraphPad Prism.
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